On September 9, AMCP submitted comments praising CMS’s proposal to cover Digital Mental Health Treatment devices (DMHTs) under Medicare Part B. AMCP urges CMS to use its authority to cover all FDA-cleared, prescription only digital health products and develop appropriate coding and payment methodologies to promote adoption of these innovative technologies.
AMCP Letter on 21st Century Cures 2.0
On Aug. 2, AMCP submitted comments in response to the 21st Century Cures 2.0 Request for Information. AMCP’s comments detail the association’s support for many of the provisions included in the Cures 2.0 Act of 2021. The bill, introduced in the previous Congress by Congresswoman Diana DeGette (D-CO), would increase coverage of innovative technologies, improve Medicaid access to high-cost therapies, and improve post-marketing studies of drugs approved through accelerated pathways.
Featured News & Resources
See Full CalendarNews & Resources by Topic
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.